• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在糖耐量受损和β细胞功能障碍的受试者中,反对胰岛素原加工对最大胰岛素分泌起限速作用的证据。

Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction.

作者信息

Stumvoll M, Fritsche A, Stefan N, Hardt E, Häring H

机构信息

Medizinische Klinik, Abteilung für Endokrinologie, Stoffwechsel und Pathobiochemie, Eberhard Karls Universität, 72076 Tubingen, Germany.

出版信息

J Clin Endocrinol Metab. 2001 Mar;86(3):1235-9. doi: 10.1210/jcem.86.3.7331.

DOI:10.1210/jcem.86.3.7331
PMID:11238514
Abstract

In subjects with impaired glucose tolerance (IGT) insulin secretion is impaired. Increased proinsulin/insulin (PI/I) ratios suggest that there is also reduced processing of proinsulin to insulin in this condition. The PI/I ratio in the insulin secretory granule is ideally assessed by plasma measurements in response to acute stimulation of insulin secretion. In the present study we tested the hypothesis that maximal stimulation of insulin secretion results in exhaustion of the proinsulin conversion pathway to insulin. We therefore determined the PI/I ratio in 11 normal glucose-tolerant subjects (NGT) and 11 subjects with IGT in response to glucose (squarewave hyperglycemic clamp, 10 mmol/L), glucagon-like peptide-1 (GLP-1; primed-continuous infusion), and arginine given during the continued GLP-1 infusion. In IGT, insulin levels were significantly lower during the first phase (144 +/- 20 vs. 397 +/- 119 pmol/L; P = 0.02), at the end of the GLP infusion (2142 +/- 350 vs. 5430 +/- 1091 pmol/L; P: = 0.002), and in response to arginine (3983 +/- 375 vs. 8663 +/- 1430 pmol/L; P = 0.005). In response to glucose, the minimum PI/I ratio was significantly higher in IGT (3.4 +/- 0.6%) than in NGT (1.4 +/- 0.5%; P = 0.02), suggesting defective proinsulin processing in this condition. In subjects with IGT, the PI/I ratio decreased significantly after GLP-1 priming (1.7 +/- 0.2%; P = 0.02) and after arginine given during GLP-1 (1.4 +/- 0.2%; P = 0.007) and was not significantly different from those values in NGT (1.3 +/- 0.2% and 1.3 +/- 0.2%, respectively; both P = NS). In conclusion, during maximal stimulation of insulin secretion in subjects with IGT, the PI/I ratio in plasma decreased significantly and was not different from that in normal controls. This strongly argues against the hypothesis that defective processing of proinsulin to insulin represents a major component of the beta-cell dysfunction in IGT.

摘要

在糖耐量受损(IGT)的受试者中,胰岛素分泌受损。胰岛素原/胰岛素(PI/I)比值升高表明在此种情况下胰岛素原向胰岛素的加工过程也有所减少。胰岛素分泌颗粒中的PI/I比值理想情况下是通过对胰岛素分泌进行急性刺激后的血浆测量来评估的。在本研究中,我们检验了以下假设:胰岛素分泌的最大刺激会导致胰岛素原转化为胰岛素的途径耗竭。因此,我们测定了11名糖耐量正常(NGT)受试者和11名IGT受试者在葡萄糖(方波高血糖钳夹,10 mmol/L)、胰高血糖素样肽-1(GLP-1;预充式持续输注)以及在持续输注GLP-1期间给予精氨酸刺激下的PI/I比值。在IGT患者中,第一阶段胰岛素水平显著较低(144±20对397±119 pmol/L;P = 0.02),在GLP输注结束时(2142±350对5430±1091 pmol/L;P = 0.002),以及对精氨酸的反应中(3983±375对8663±1430 pmol/L;P = 0.005)。对葡萄糖的反应中,IGT患者的最低PI/I比值显著高于NGT患者(3.4±0.6%对1.4±0.5%;P = 0.02),提示在此种情况下胰岛素原加工存在缺陷。在IGT患者中,GLP-1预充后PI/I比值显著下降(1.7±0.2%;P = 0.02),在GLP-1输注期间给予精氨酸后也下降(1.4±0.2%;P = 0.007),且与NGT患者的值无显著差异(分别为1.3±0.2%和1.3±0.2%;P均=无统计学意义)。总之,在IGT患者胰岛素分泌的最大刺激过程中,血浆中的PI/I比值显著下降,且与正常对照组无异。这有力地反驳了胰岛素原加工缺陷是IGT中β细胞功能障碍主要组成部分的假设。

相似文献

1
Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction.在糖耐量受损和β细胞功能障碍的受试者中,反对胰岛素原加工对最大胰岛素分泌起限速作用的证据。
J Clin Endocrinol Metab. 2001 Mar;86(3):1235-9. doi: 10.1210/jcem.86.3.7331.
2
Characterisation of beta-cell dysfunction of impaired glucose tolerance: evidence for impairment of incretin-induced insulin secretion.糖耐量受损时β细胞功能障碍的特征:肠促胰岛素诱导的胰岛素分泌受损的证据。
Diabetologia. 2000 Jul;43(7):852-8. doi: 10.1007/s001250051461.
3
Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance.胰高血糖素样肽1可改善糖耐量受损患者β细胞感知和响应葡萄糖的能力。
Diabetes. 1998 Aug;47(8):1259-65. doi: 10.2337/diab.47.8.1259.
4
Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance.相对高胰岛素原血症作为糖耐量受损女性胰岛功能障碍的一个标志。
J Clin Endocrinol Metab. 1999 Jun;84(6):2068-74. doi: 10.1210/jcem.84.6.5717.
5
Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.使用胰高血糖素样肽-1评估β细胞分泌能力。
Diabetes Care. 2000 Jun;23(6):807-12. doi: 10.2337/diacare.23.6.807.
6
[Proportion of proinsulin two minutes after arginine stimulation: a pilot study].[精氨酸刺激后两分钟胰岛素原的比例:一项初步研究]
Zhonghua Yi Xue Za Zhi. 2005 Sep 14;85(35):2477-80.
7
Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.糖耐量受损的非肥胖受试者口服葡萄糖后的胰岛素分泌及肠促胰岛素激素
Metabolism. 2004 May;53(5):624-31. doi: 10.1016/j.metabol.2003.11.011.
8
Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans.胰高血糖素样肽-1急性输注和长期输注对糖尿病和非糖尿病患者第一相和第二相胰岛素分泌的不同影响。
Diabetes Care. 2003 Mar;26(3):791-8. doi: 10.2337/diacare.26.3.791.
9
Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance.糖耐量受损的绝经后女性中,胰岛素抵抗所致的胰岛功能障碍涉及胰岛素分泌受损和胰高血糖素分泌增加。
Diabetes Care. 2000 May;23(5):650-7. doi: 10.2337/diacare.23.5.650.
10
Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.通过对非胰岛素依赖型糖尿病患者夜间输注胰高血糖素样肽1(7-36)酰胺使胰岛素对葡萄糖的反应正常化。
Diabetes. 1996 Nov;45(11):1524-30. doi: 10.2337/diab.45.11.1524.

引用本文的文献

1
Both fasting and glucose-stimulated proinsulin levels predict hyperglycemia and incident type 2 diabetes: a population-based study of 9,396 Finnish men.空腹及葡萄糖刺激后的胰岛素原水平均能预测高血糖及2型糖尿病的发病:一项基于9396名芬兰男性的人群研究。
PLoS One. 2015 Apr 8;10(4):e0124028. doi: 10.1371/journal.pone.0124028. eCollection 2015.
2
GLP-1(28-36)amide, the Glucagon-like peptide-1 metabolite: friend, foe, or pharmacological folly?胰高血糖素样肽-1代谢产物GLP-1(28-36)酰胺:是益友、敌人还是药理学上的愚蠢之举?
Drug Des Devel Ther. 2014 Jun 3;8:677-88. doi: 10.2147/DDDT.S35723. eCollection 2014.
3
Polymorphism rs11085226 in the gene encoding polypyrimidine tract-binding protein 1 negatively affects glucose-stimulated insulin secretion.
基因编码多嘧啶 tract 结合蛋白 1 中的 rs11085226 多态性负调控葡萄糖刺激的胰岛素分泌。
PLoS One. 2012;7(10):e46154. doi: 10.1371/journal.pone.0046154. Epub 2012 Oct 15.
4
In type 2 diabetes patients, insulin glargine is associated with lower postprandial release of intact proinsulin compared with sulfonylurea treatment.在2型糖尿病患者中,与磺脲类药物治疗相比,甘精胰岛素与较低的完整胰岛素原餐后释放量相关。
J Diabetes Sci Technol. 2012 May 1;6(3):634-40. doi: 10.1177/193229681200600318.
5
Cardiovascular benefits of GLP-1-based herapies in patients with diabetes mellitus type 2: effects on endothelial and vascular dysfunction beyond glycemic control.基于胰高血糖素样肽-1(GLP-1)的疗法对2型糖尿病患者的心血管益处:对血糖控制以外的内皮和血管功能障碍的影响
Exp Diabetes Res. 2012;2012:635472. doi: 10.1155/2012/635472. Epub 2012 Apr 17.
6
Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion.TCF7L2、CDKAL1和SLC30A8基因的多态性与胰岛素原转化受损有关。
Diabetologia. 2008 Apr;51(4):597-601. doi: 10.1007/s00125-008-0926-y. Epub 2008 Feb 9.